408 related articles for article (PubMed ID: 15745782)
1. Iris and anterior chamber angle neovascularization after iodine 125 brachytherapy for uveal melanoma.
Detorakis ET; Engstrom RE; Wallace R; Straatsma BR
Ophthalmology; 2005 Mar; 112(3):505-10. PubMed ID: 15745782
[TBL] [Abstract][Full Text] [Related]
2. Ocular complications after iodine brachytherapy for large uveal melanomas.
Puusaari I; Heikkonen J; Kivelä T
Ophthalmology; 2004 Sep; 111(9):1768-77. PubMed ID: 15350335
[TBL] [Abstract][Full Text] [Related]
3. Proliferative radiation retinopathy after plaque radiotherapy for uveal melanoma.
Bianciotto C; Shields CL; Pirondini C; Mashayekhi A; Furuta M; Shields JA
Ophthalmology; 2010 May; 117(5):1005-12. PubMed ID: 20079924
[TBL] [Abstract][Full Text] [Related]
4. Pigmented episcleral deposits after brachytherapy of uveal melanoma.
Toivonen P; Kivelä T
Ophthalmology; 2006 May; 113(5):865-73. PubMed ID: 16530837
[TBL] [Abstract][Full Text] [Related]
5. Effect of radiation dose on ocular complications after iodine brachytherapy for large uveal melanoma: empirical data and simulation of collimating plaques.
Puusaari I; Heikkonen J; Kivelä T
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3425-34. PubMed ID: 15452045
[TBL] [Abstract][Full Text] [Related]
6. Tumor-related lipid exudation after plaque radiotherapy of choroidal melanoma: the role of Bruch's membrane rupture.
Mashayekhi A; Tuncer S; Shields CL; Shields JA
Ophthalmology; 2010 May; 117(5):1013-23. PubMed ID: 20097428
[TBL] [Abstract][Full Text] [Related]
7. Corneoscleral necrosis after episcleral Au-198 brachytherapy of uveal melanoma.
Chaudhry IA; Liu M; Shamsi FA; Arat YO; Shetlar DJ; Boniuk M
Retina; 2009 Jan; 29(1):73-9. PubMed ID: 18728617
[TBL] [Abstract][Full Text] [Related]
8. [The analysis of I125 brachytherapy complications in cases of uveal melanoma].
Pogrzebielski A; Starzycka M; Romanowska-Dixon B; Jakubowska B; Szpakowicz U
Klin Oczna; 2005; 107(1-3):49-53. PubMed ID: 16052800
[TBL] [Abstract][Full Text] [Related]
9. Early macular morphological changes following plaque radiotherapy for uveal melanoma.
Horgan N; Shields CL; Mashayekhi A; Teixeira LF; Materin MA; Shields JA
Retina; 2008 Feb; 28(2):263-73. PubMed ID: 18301032
[TBL] [Abstract][Full Text] [Related]
10. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation.
Krohn J; Monge OR; Skorpen TN; Mørk SJ; Dahl O
Eye (Lond); 2008 Nov; 22(11):1398-403. PubMed ID: 17585309
[TBL] [Abstract][Full Text] [Related]
11. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
[TBL] [Abstract][Full Text] [Related]
12. Periocular triamcinolone for prevention of macular edema after iodine 125 plaque radiotherapy of uveal melanoma.
Horgan N; Shields CL; Mashayekhi A; Teixeira LF; Materin MA; O'Regan M; Shields JA
Retina; 2008; 28(7):987-95. PubMed ID: 18698302
[TBL] [Abstract][Full Text] [Related]
13. Scleral necrosis after plaque radiotherapy of uveal melanoma: a case-control study.
Kaliki S; Shields CL; Rojanaporn D; Badal J; Devisetty L; Emrich J; Komarnicky L; Shields JA
Ophthalmology; 2013 May; 120(5):1004-11. PubMed ID: 23347983
[TBL] [Abstract][Full Text] [Related]
14. Lipid exudation following plaque radiotherapy for posterior uveal melanoma.
Mills MD; Harbour JW
Am J Ophthalmol; 2006 Mar; 141(3):594-595. PubMed ID: 16490526
[TBL] [Abstract][Full Text] [Related]
15. Histopathologic findings in large uveal melanomas after brachytherapy with iodine 125 ophthalmic plaques.
Schilling H; Bornfeld N; Friedrichs W; Pauleikhoff D; Sauerwein W; Wessing A
Ger J Ophthalmol; 1994 Aug; 3(4-5):232-8. PubMed ID: 7804109
[TBL] [Abstract][Full Text] [Related]
16. Glaucoma After Iodine-125 Brachytherapy for Uveal Melanoma: Incidence and Risk Factors.
Kim EA; Salazar D; McCannel CA; Kamrava M; Demanes DJ; Lamb J; Caprioli J; McCannel TA
J Glaucoma; 2020 Jan; 29(1):1-10. PubMed ID: 31688338
[TBL] [Abstract][Full Text] [Related]
17. Proton beam therapy and iris neovascularisation in uveal melanoma.
Boyd SR; Gittos A; Richter M; Hungerford JL; Errington RD; Cree IA
Eye (Lond); 2006 Jul; 20(7):832-6. PubMed ID: 16167079
[TBL] [Abstract][Full Text] [Related]
18. Incidence of cataract and outcomes after cataract surgery in the first 5 years after iodine 125 brachytherapy in the Collaborative Ocular Melanoma Study: COMS Report No. 27.
Collaborative Ocular Melanoma Study Group
Ophthalmology; 2007 Jul; 114(7):1363-71. PubMed ID: 17337065
[TBL] [Abstract][Full Text] [Related]
19. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
[TBL] [Abstract][Full Text] [Related]
20. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]